Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histocompatibility Antigens Class II | 26 | 2018 | 1537 | 1.970 |
Why?
|
Genes, MHC Class II | 14 | 2003 | 509 | 1.220 |
Why?
|
Swine, Miniature | 31 | 2014 | 953 | 1.180 |
Why?
|
Retroviridae | 23 | 2010 | 957 | 1.080 |
Why?
|
HLA-DQ Antigens | 9 | 2003 | 233 | 1.050 |
Why?
|
Bone Marrow Cells | 20 | 2010 | 2596 | 0.960 |
Why?
|
Swine | 53 | 2021 | 5763 | 0.950 |
Why?
|
Transplantation Tolerance | 6 | 2013 | 614 | 0.900 |
Why?
|
Kidney Transplantation | 16 | 2014 | 4116 | 0.750 |
Why?
|
Major Histocompatibility Complex | 15 | 2011 | 1022 | 0.680 |
Why?
|
Graft Rejection | 12 | 2018 | 4408 | 0.660 |
Why?
|
Gene Transfer Techniques | 11 | 2002 | 1299 | 0.620 |
Why?
|
Bone Marrow Transplantation | 16 | 2010 | 2789 | 0.600 |
Why?
|
Transfection | 18 | 2004 | 6161 | 0.590 |
Why?
|
Genetic Vectors | 21 | 2010 | 3563 | 0.570 |
Why?
|
Transplantation Immunology | 7 | 2005 | 583 | 0.540 |
Why?
|
HLA-DR Antigens | 10 | 2002 | 696 | 0.530 |
Why?
|
Reperfusion Injury | 1 | 2021 | 1071 | 0.530 |
Why?
|
Immune Tolerance | 13 | 2014 | 2333 | 0.500 |
Why?
|
Transplantation, Heterologous | 9 | 2021 | 2427 | 0.500 |
Why?
|
Graft Survival | 10 | 2013 | 3767 | 0.490 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2018 | 3055 | 0.480 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2018 | 2498 | 0.460 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 2001 | 99 | 0.430 |
Why?
|
Hematopoietic Stem Cells | 10 | 2000 | 3447 | 0.430 |
Why?
|
Transplantation, Homologous | 12 | 2014 | 4831 | 0.420 |
Why?
|
Liver Transplantation | 1 | 2021 | 2022 | 0.410 |
Why?
|
Histocompatibility Antigens Class I | 8 | 2007 | 1418 | 0.400 |
Why?
|
Skin Transplantation | 7 | 2013 | 1130 | 0.380 |
Why?
|
Organ Transplantation | 3 | 2011 | 1071 | 0.350 |
Why?
|
T-Lymphocytes | 11 | 2021 | 10362 | 0.340 |
Why?
|
Cytokines | 6 | 2011 | 7189 | 0.330 |
Why?
|
H-2 Antigens | 3 | 1997 | 402 | 0.320 |
Why?
|
Genes, MHC Class I | 4 | 1997 | 280 | 0.320 |
Why?
|
Dendritic Cells | 3 | 2011 | 2726 | 0.320 |
Why?
|
Animals | 82 | 2022 | 170486 | 0.290 |
Why?
|
Lymphocyte Activation | 8 | 2022 | 5908 | 0.270 |
Why?
|
Transduction, Genetic | 8 | 2010 | 970 | 0.270 |
Why?
|
Thymus Gland | 2 | 2000 | 1328 | 0.250 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 2002 | 365 | 0.250 |
Why?
|
Renal Circulation | 1 | 2004 | 347 | 0.240 |
Why?
|
Disaccharides | 2 | 2002 | 175 | 0.230 |
Why?
|
Flow Cytometry | 13 | 2014 | 6127 | 0.220 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2001 | 73 | 0.220 |
Why?
|
Complementarity Determining Regions | 1 | 2001 | 160 | 0.210 |
Why?
|
Leukocytes, Mononuclear | 2 | 2021 | 1719 | 0.200 |
Why?
|
Antigen Presentation | 4 | 2003 | 1303 | 0.190 |
Why?
|
Mice | 28 | 2022 | 80876 | 0.190 |
Why?
|
Base Sequence | 14 | 2001 | 13352 | 0.190 |
Why?
|
Heart Transplantation | 3 | 2013 | 3079 | 0.190 |
Why?
|
Colony-Forming Units Assay | 7 | 2003 | 372 | 0.180 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2018 | 4383 | 0.180 |
Why?
|
Blotting, Northern | 5 | 2000 | 1636 | 0.180 |
Why?
|
DNA, Recombinant | 1 | 1999 | 502 | 0.170 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2001 | 821 | 0.170 |
Why?
|
T-Lymphocyte Subsets | 5 | 2013 | 1924 | 0.160 |
Why?
|
Lymphocyte Culture Test, Mixed | 5 | 2021 | 614 | 0.160 |
Why?
|
Antigens, CD1 | 1 | 2000 | 476 | 0.160 |
Why?
|
Blotting, Southern | 5 | 2003 | 828 | 0.160 |
Why?
|
Cloning, Molecular | 12 | 2001 | 4489 | 0.150 |
Why?
|
Thymectomy | 1 | 1997 | 199 | 0.150 |
Why?
|
Kidney | 3 | 1997 | 6888 | 0.150 |
Why?
|
B-Lymphocytes | 3 | 2022 | 4861 | 0.150 |
Why?
|
Transgenes | 3 | 2003 | 1026 | 0.150 |
Why?
|
Cytotoxicity, Immunologic | 4 | 2004 | 1499 | 0.150 |
Why?
|
Promoter Regions, Genetic | 6 | 2000 | 6068 | 0.150 |
Why?
|
Repetitive Sequences, Nucleic Acid | 5 | 1996 | 816 | 0.140 |
Why?
|
Rabbits | 7 | 1991 | 5163 | 0.140 |
Why?
|
Molecular Sequence Data | 14 | 2003 | 18748 | 0.130 |
Why?
|
Transcription, Genetic | 11 | 2002 | 7965 | 0.130 |
Why?
|
Bone Marrow | 6 | 1996 | 2938 | 0.130 |
Why?
|
Gene Expression | 10 | 2002 | 8014 | 0.130 |
Why?
|
Restriction Mapping | 6 | 1996 | 915 | 0.120 |
Why?
|
Antigens | 1 | 2018 | 1507 | 0.120 |
Why?
|
Interleukin-3 | 5 | 2003 | 439 | 0.120 |
Why?
|
Polymerase Chain Reaction | 7 | 2003 | 6293 | 0.110 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9927 | 0.110 |
Why?
|
Gene Expression Regulation | 6 | 2004 | 12447 | 0.110 |
Why?
|
Stem Cell Factor | 4 | 2003 | 223 | 0.110 |
Why?
|
DNA, Viral | 1 | 1999 | 2287 | 0.110 |
Why?
|
Ligands | 1 | 2018 | 3297 | 0.110 |
Why?
|
3T3 Cells | 3 | 1999 | 1126 | 0.110 |
Why?
|
Recombinant Proteins | 7 | 2000 | 6850 | 0.110 |
Why?
|
Amino Acid Sequence | 11 | 2003 | 14215 | 0.110 |
Why?
|
Transplants | 1 | 2013 | 202 | 0.100 |
Why?
|
HLA Antigens | 2 | 2012 | 1549 | 0.100 |
Why?
|
Antigenic Variation | 1 | 2011 | 128 | 0.100 |
Why?
|
Autoimmunity | 1 | 2018 | 1325 | 0.100 |
Why?
|
DNA Primers | 3 | 2001 | 3002 | 0.100 |
Why?
|
Interferon-gamma | 3 | 2013 | 3245 | 0.100 |
Why?
|
Gene Deletion | 1 | 1998 | 2838 | 0.100 |
Why?
|
Thymidine Kinase | 3 | 1996 | 298 | 0.100 |
Why?
|
Kanamycin Kinase | 3 | 2000 | 34 | 0.090 |
Why?
|
Papio | 5 | 2002 | 672 | 0.090 |
Why?
|
Sequence Homology, Nucleic Acid | 7 | 2001 | 1134 | 0.090 |
Why?
|
Interleukin-10 | 1 | 1995 | 1213 | 0.090 |
Why?
|
Mice, Inbred CBA | 1 | 2010 | 486 | 0.090 |
Why?
|
Clone Cells | 3 | 2001 | 1767 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2002 | 5135 | 0.090 |
Why?
|
Intracellular Space | 1 | 2010 | 214 | 0.090 |
Why?
|
Luminescent Proteins | 2 | 2003 | 885 | 0.090 |
Why?
|
Mice, Inbred Strains | 3 | 1997 | 1922 | 0.090 |
Why?
|
Histocompatibility Testing | 4 | 2002 | 804 | 0.090 |
Why?
|
Cell Movement | 1 | 2001 | 5489 | 0.080 |
Why?
|
Endothelium | 3 | 2000 | 810 | 0.080 |
Why?
|
Chimera | 2 | 2001 | 477 | 0.080 |
Why?
|
Sequence Alignment | 3 | 2001 | 2281 | 0.080 |
Why?
|
Killer Cells, Natural | 3 | 2004 | 2165 | 0.080 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2000 | 903 | 0.080 |
Why?
|
Cells, Cultured | 7 | 2000 | 20170 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4424 | 0.070 |
Why?
|
Transplantation Conditioning | 2 | 2003 | 1553 | 0.070 |
Why?
|
CD40 Ligand | 2 | 2021 | 533 | 0.070 |
Why?
|
Humans | 34 | 2021 | 708843 | 0.070 |
Why?
|
Graft Enhancement, Immunologic | 2 | 2013 | 61 | 0.070 |
Why?
|
DNA, Complementary | 2 | 2002 | 2100 | 0.070 |
Why?
|
Mice, Inbred BALB C | 3 | 2013 | 6684 | 0.070 |
Why?
|
Culture Techniques | 2 | 1996 | 572 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2001 | 2926 | 0.060 |
Why?
|
Cyclosporine | 2 | 1997 | 826 | 0.060 |
Why?
|
Signal Transduction | 2 | 2022 | 23950 | 0.060 |
Why?
|
Cell Line | 7 | 2004 | 16657 | 0.060 |
Why?
|
Cross Reactions | 2 | 2012 | 879 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2013 | 22989 | 0.060 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1993 | 741 | 0.050 |
Why?
|
Polymorphism, Genetic | 4 | 2001 | 4293 | 0.050 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2003 | 277 | 0.050 |
Why?
|
Alleles | 4 | 2007 | 7090 | 0.050 |
Why?
|
Cell Lineage | 1 | 2011 | 2630 | 0.050 |
Why?
|
Genetic Engineering | 2 | 2001 | 953 | 0.050 |
Why?
|
Models, Immunological | 1 | 2003 | 529 | 0.050 |
Why?
|
DNA | 6 | 1993 | 7172 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16306 | 0.050 |
Why?
|
Down-Regulation | 2 | 2000 | 3093 | 0.050 |
Why?
|
Transplantation Chimera | 1 | 2003 | 623 | 0.050 |
Why?
|
Catalysis | 1 | 2022 | 822 | 0.050 |
Why?
|
Immunization, Secondary | 1 | 2002 | 341 | 0.050 |
Why?
|
Transplantation, Autologous | 3 | 2001 | 2092 | 0.050 |
Why?
|
Tetracycline | 1 | 2000 | 219 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2022 | 813 | 0.050 |
Why?
|
Cell Adhesion | 3 | 2004 | 3318 | 0.050 |
Why?
|
Genes | 4 | 1990 | 1977 | 0.050 |
Why?
|
Cell Division | 3 | 2002 | 4752 | 0.050 |
Why?
|
Antigens, Polyomavirus Transforming | 2 | 2001 | 280 | 0.050 |
Why?
|
Skin | 1 | 2013 | 4325 | 0.050 |
Why?
|
Plasmids | 2 | 1999 | 2498 | 0.050 |
Why?
|
Simplexvirus | 2 | 1995 | 809 | 0.050 |
Why?
|
Immunoblotting | 1 | 2003 | 1795 | 0.050 |
Why?
|
Doxycycline | 1 | 2000 | 308 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2000 | 3878 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2022 | 570 | 0.040 |
Why?
|
Cell Transformation, Viral | 1 | 2001 | 672 | 0.040 |
Why?
|
Superantigens | 1 | 1998 | 128 | 0.040 |
Why?
|
Lymphocytes | 3 | 2003 | 2729 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2021 | 874 | 0.040 |
Why?
|
Proviruses | 1 | 1999 | 272 | 0.040 |
Why?
|
Germ-Free Life | 1 | 1998 | 193 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2021 | 1026 | 0.040 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1999 | 315 | 0.040 |
Why?
|
Green Fluorescent Proteins | 2 | 2003 | 2193 | 0.040 |
Why?
|
Cell Separation | 2 | 2002 | 1835 | 0.040 |
Why?
|
Isoantigens | 1 | 2000 | 579 | 0.040 |
Why?
|
Hybrid Cells | 1 | 1997 | 464 | 0.040 |
Why?
|
Antigens, Heterophile | 1 | 1997 | 72 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2000 | 637 | 0.040 |
Why?
|
HLA-C Antigens | 1 | 1997 | 168 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 617 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2021 | 1374 | 0.040 |
Why?
|
Multigene Family | 1 | 2001 | 1125 | 0.040 |
Why?
|
Haploidy | 1 | 1997 | 155 | 0.040 |
Why?
|
RNA, Messenger | 4 | 2002 | 13314 | 0.040 |
Why?
|
Cryopreservation | 1 | 2021 | 618 | 0.040 |
Why?
|
Immunity | 1 | 2001 | 957 | 0.040 |
Why?
|
Sarcoma Viruses, Murine | 1 | 1995 | 67 | 0.040 |
Why?
|
Phosphoglycerate Kinase | 1 | 1995 | 66 | 0.040 |
Why?
|
Animals, Genetically Modified | 1 | 2001 | 1589 | 0.040 |
Why?
|
Species Specificity | 2 | 1994 | 2619 | 0.040 |
Why?
|
Radiation Chimera | 1 | 1995 | 229 | 0.030 |
Why?
|
Transplantation, Isogeneic | 1 | 1995 | 283 | 0.030 |
Why?
|
Simian virus 40 | 2 | 1996 | 316 | 0.030 |
Why?
|
Gene Library | 2 | 1995 | 1094 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1993 | 0.030 |
Why?
|
Isoantibodies | 1 | 1997 | 660 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2011 | 11718 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 1996 | 673 | 0.030 |
Why?
|
Antigens, CD | 2 | 2021 | 4169 | 0.030 |
Why?
|
Animals, Wild | 2 | 1990 | 77 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 233 | 0.030 |
Why?
|
Immunoglobulin Isotypes | 2 | 1995 | 160 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 1997 | 4254 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1996 | 778 | 0.030 |
Why?
|
Cell Line, Transformed | 3 | 2001 | 989 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3812 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1995 | 421 | 0.030 |
Why?
|
Phosphotransferases | 1 | 1993 | 311 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 2013 | 1021 | 0.030 |
Why?
|
Monocytes | 2 | 2003 | 2660 | 0.030 |
Why?
|
DNA Probes | 2 | 1990 | 562 | 0.030 |
Why?
|
Erythropoietin | 1 | 1996 | 731 | 0.030 |
Why?
|
Interleukins | 1 | 1996 | 799 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4941 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2002 | 4658 | 0.030 |
Why?
|
Muridae | 1 | 1990 | 65 | 0.030 |
Why?
|
Fluorouracil | 1 | 1996 | 1620 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2004 | 5141 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2004 | 3417 | 0.030 |
Why?
|
RNA, Viral | 1 | 1999 | 2847 | 0.020 |
Why?
|
Models, Genetic | 1 | 2000 | 3539 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 958 | 0.020 |
Why?
|
Fibroblasts | 1 | 2000 | 4299 | 0.020 |
Why?
|
Coronary Disease | 1 | 2004 | 6127 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 1995 | 1849 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 1989 | 284 | 0.020 |
Why?
|
Organ Specificity | 1 | 2013 | 2064 | 0.020 |
Why?
|
Pilot Projects | 1 | 2001 | 7994 | 0.020 |
Why?
|
Biological Evolution | 5 | 1991 | 1084 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2673 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 1995 | 2264 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3968 | 0.020 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1989 | 648 | 0.020 |
Why?
|
Antigen-Presenting Cells | 2 | 2002 | 981 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 1993 | 3972 | 0.020 |
Why?
|
HLA-DP Antigens | 1 | 1985 | 35 | 0.020 |
Why?
|
Time Factors | 2 | 2000 | 41038 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 1991 | 1708 | 0.020 |
Why?
|
Stem Cells | 1 | 1998 | 3593 | 0.020 |
Why?
|
Antibodies, Monoclonal | 4 | 2013 | 9584 | 0.020 |
Why?
|
Leukapheresis | 1 | 2003 | 128 | 0.020 |
Why?
|
Exons | 1 | 1990 | 2472 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1997 | 4226 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2004 | 229 | 0.020 |
Why?
|
Myeloid Progenitor Cells | 1 | 2003 | 114 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 1995 | 4422 | 0.010 |
Why?
|
Erythroid Precursor Cells | 1 | 2003 | 226 | 0.010 |
Why?
|
RNA | 1 | 1993 | 2680 | 0.010 |
Why?
|
Histocompatibility | 1 | 2004 | 362 | 0.010 |
Why?
|
Busulfan | 1 | 2003 | 271 | 0.010 |
Why?
|
Immunogenetics | 1 | 2001 | 80 | 0.010 |
Why?
|
Multipotent Stem Cells | 1 | 2003 | 201 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2000 | 6991 | 0.010 |
Why?
|
Solubility | 1 | 2004 | 1156 | 0.010 |
Why?
|
Molecular Probes | 1 | 2004 | 326 | 0.010 |
Why?
|
Granulocytes | 1 | 2003 | 562 | 0.010 |
Why?
|
Neutrophil Infiltration | 1 | 2004 | 407 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1990 | 4837 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 2000 | 201 | 0.010 |
Why?
|
Transplantation | 1 | 2002 | 228 | 0.010 |
Why?
|
Fracture Healing | 1 | 2002 | 405 | 0.010 |
Why?
|
Electroporation | 1 | 2001 | 251 | 0.010 |
Why?
|
Female | 6 | 2010 | 375205 | 0.010 |
Why?
|
Adenoviridae | 1 | 2002 | 1135 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 1989 | 792 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1997 | 379 | 0.010 |
Why?
|
Mice, Inbred A | 1 | 1997 | 254 | 0.010 |
Why?
|
Clonal Deletion | 1 | 1997 | 80 | 0.010 |
Why?
|
Haplotypes | 2 | 1997 | 2874 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2003 | 803 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1996 | 459 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1995 | 330 | 0.010 |
Why?
|
Aorta | 1 | 2002 | 2120 | 0.010 |
Why?
|
Hematopoietic System | 1 | 1994 | 115 | 0.010 |
Why?
|
Tissue Donors | 1 | 2003 | 2147 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 1996 | 955 | 0.010 |
Why?
|
Epitopes | 1 | 2000 | 2646 | 0.010 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1996 | 447 | 0.010 |
Why?
|
Hypersensitivity | 1 | 2001 | 1019 | 0.010 |
Why?
|
Antigens, Surface | 1 | 1997 | 1858 | 0.010 |
Why?
|
Immunophenotyping | 1 | 1997 | 1908 | 0.010 |
Why?
|
Pseudogenes | 1 | 1991 | 116 | 0.010 |
Why?
|
Wound Healing | 1 | 2002 | 2800 | 0.010 |
Why?
|
Neutrophils | 1 | 2004 | 3867 | 0.010 |
Why?
|
Antibody Formation | 1 | 1995 | 1419 | 0.010 |
Why?
|
Stromal Cells | 1 | 1996 | 1361 | 0.010 |
Why?
|
Myocardium | 1 | 2004 | 4969 | 0.010 |
Why?
|
Introns | 1 | 1991 | 1015 | 0.010 |
Why?
|
Kinetics | 1 | 1996 | 6796 | 0.010 |
Why?
|
Fetal Blood | 1 | 1994 | 1334 | 0.000 |
Why?
|
Apoptosis | 1 | 2004 | 10085 | 0.000 |
Why?
|
Immunotherapy | 1 | 2001 | 4057 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 2002 | 8024 | 0.000 |
Why?
|
Interleukin-6 | 1 | 1996 | 3179 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2004 | 18375 | 0.000 |
Why?
|
Spleen | 1 | 1990 | 2473 | 0.000 |
Why?
|
Structure-Activity Relationship | 1 | 1990 | 3209 | 0.000 |
Why?
|
Hematopoiesis | 1 | 1994 | 2015 | 0.000 |
Why?
|
Neoplasms | 2 | 2002 | 20172 | 0.000 |
Why?
|
Pedigree | 1 | 1991 | 4724 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1987 | 2428 | 0.000 |
Why?
|
Enhancer Elements, Genetic | 1 | 1989 | 1378 | 0.000 |
Why?
|
Models, Molecular | 1 | 1990 | 5525 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2002 | 14075 | 0.000 |
Why?
|
Age Factors | 1 | 1994 | 18712 | 0.000 |
Why?
|
Models, Biological | 1 | 1993 | 9907 | 0.000 |
Why?
|
Genetic Variation | 1 | 1990 | 6666 | 0.000 |
Why?
|
Male | 1 | 1991 | 349524 | 0.000 |
Why?
|